Table 1.
Correlation Between Dynamin2 Expression and Clinicopathological Characteristics
| Factors | Dynamin2 | P | |
|---|---|---|---|
|
| |||
| Negative No. | Positive No. | ||
| Gender | 0.207 | ||
| Male | 41 | 67 | |
| Female | 12 | 11 | |
| Age | 0.486 | ||
| ≤ 54 years | 25 | 32 | |
| > 54 years | 28 | 46 | |
| HBsAg | 0.174 | ||
| Negative | 5 | 14 | |
| Positive | 48 | 64 | |
| HCV-Ab | 0.686 | ||
| Negative | 52 | 75 | |
| Positive | 1 | 1 | |
| Cirr-nodul | 0.173 | ||
| None | 7 | 18 | |
| Micro | 45 | 60 | |
| AFP | 0.032 | ||
| ≤ 20 ng/ml | 14 | 35 | |
| > 20 ng/ml | 39 | 43 | |
| Thrumbi | 0.475 | ||
| No | 30 | 49 | |
| Yes | 23 | 29 | |
| Tumor size | 0.096 | ||
| < 5 cm | 13 | 30 | |
| > 5 cm | 40 | 48 | |
| Tumor number | 0.063 | ||
| Singer | 48 | 61 | |
| Multiple | 5 | 17 | |
| Encapsulation | 0.539 | ||
| Complete | 24 | 37 | |
| None | 29 | 41 | |
| Edmondson Stage | 0.822 | ||
| I/II | 39 | 56 | |
| III/IV | 14 | 22 | |
| TNM stage | 0.759 | ||
| I/II | 40 | 57 | |
| III | 13 | 21 | |
AFP, alpha-fetoprotein; TNM, tumor nodule metastasis.